Latest News

What Skin Manifestations Are Associated With Pediatric IBD?


 

TOPLINE:

Skin conditions burden many children with inflammatory bowel disease (IBD), according to the authors of a single-center study.

METHODOLOGY:

  • Little is known about the prevalence of IBD-associated skin lesions and their association with IBD severity in children ages 18 and younger.Researchers retrospectively reviewed the medical charts of 425 children and adolescents with (CD) or ulcerative (UC) at one or more dermatologic diagnoses who were seen at Mayo Clinic, Rochester, Minnesota, between 1999 and 2017.
  • Of the children studied, 53% were male, 64.9% had CD, and 42.8% had one or more cutaneous infections.
  • They used the chi-square/Fischer’s exact test to compare categorical outcomes between patients with CD and UC and to detect differences in IBD/CD/UC disease severity and skin conditions.
  • Researchers retrospectively reviewed the medical charts of 425 children and adolescents with Crohn’s disease (CD) or ulcerative colitis (UC) at one or more dermatologic diagnoses who were seen at Mayo Clinic, Rochester, Minnesota, between 1999 and 2017.
  • Of the children studied, 53% were male, 64.9% had CD, and 42.8% had one or more cutaneous infections.
  • They used the chi-square/Fischer’s exact test to compare categorical outcomes between patients with CD and UC and to detect differences in IBD/CD/UC disease severity and skin conditions.

TAKEAWAY:

  • The most common noninfectious dermatologic condition among the 425 children and adolescents was (30.8%), followed by eczema (15.8%) and perianal skin tags (14.6%).
  • Angular cheilitis was more common among those with CD than those with UC (7.2% vs 2%, respectively; P = .024) as was keratosis pilaris (6.9% vs 0.7%; P = .003), and perianal skin complications such as skin tags (20.3% vs 4%), fistulas (13.4% vs 2.7%), and abscesses (13.4% vs 2%; P < .001 for all associations).
  • Fungal skin infections were more frequently diagnosed in children with UC than those with CD (15.4% vs 8%; P = .017).
  • The researchers observed that the severity of IBD correlated with a higher prevalence of perianal fistula (P = .003), perianal region abscess (P = .041), psoriasis (P < .001), and pyoderma gangrenosum (P = .003).

IN PRACTICE:

“Early identification of common dermatologic conditions in children and adolescents with IBD and recognizing their characteristic associations may alter management and improve skin-related outcomes in this patient population,” the authors wrote.

SOURCE:

Corresponding author Megha M. Tollefson, MD, of the Department of Dermatology at Mayo Clinic, Rochester, Minnesota, and colleagues conducted the research, which was published in Pediatric Dermatology.

LIMITATIONS:

The single-center design and the fact that database studies are subject to extraction error. There was no age- and sex-matched cohort to determine whether the prevalence of cutaneous infections, acne, eczema, and other inflammatory disorders was truly increased in IBD.

DISCLOSURES:

The researchers reported having no disclosures.

A version of this article appeared on Medscape.com.

Recommended Reading

FDA Gives Nod to Berdazimer Gel for Molluscum Contagiosum
MDedge Dermatology
Study Identifies Cardiovascular Comorbidities Associated With Dermatomyositis
MDedge Dermatology
A 27-year-old Haitian woman presented with a painful umbilical mass which had been growing in size for 5 months
MDedge Dermatology
Cutaneous lupus, dermatomyositis: Excitement growing around emerging therapies
MDedge Dermatology
Rituximab Results in Sustained Remission for Pemphigus, Study Found
MDedge Dermatology
Success with Sirolimus in Treating Skin Sarcoidosis Could Spur Studies in Other Organs
MDedge Dermatology
New Tools on the Horizon for Managing cSCC in Solid Organ Transplant Recipients
MDedge Dermatology
Survey: Dermatology Residents Shortchanged on Sensitive Skin Education
MDedge Dermatology
Pretreatment Lab Testing for Chronic Skin Diseases Diverges From Guidelines
MDedge Dermatology
Company Announces Regulatory Filing for Nemolizumab for Two Indications
MDedge Dermatology